Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Istvan J Enyedy

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Medicinal Chemistry|March 23, 2004
Virtual screening for kinase targetsIngo Muegge, Istvan J Enyedy
Future Medicinal Chemistry|April 1, 2015
Computational solvent mapping in structure-based drug designDavid R Hall, Istvan J Enyedy
Future Medicinal Chemistry|September 16, 2016
The use of fake ligands from computational solvent mapping in ligand and structure-based virtual screeningDavid R Hall, Istvan J Enyedy
Journal of Computer-Aided Molecular Design|January 10, 2008
Can we use docking and scoring for hit-to-lead optimization?Istvan J Enyedy, William J Egan
Bioorganic & Medicinal Chemistry Letters|January 28, 2021
The influence of calculated physicochemical properties of compounds on their ADMET profilesShifan Ma, Mark McGann, Istvan J Enyedy
Future Medicinal Chemistry|April 30, 2015
In silico prediction of hERG inhibitionYankang Jing, Alison Easter, David Peters, et al.
Chemical Research in Toxicology|July 27, 2022
Use of Solvent Mapping for Characterizing the Binding Site and for Predicting the Inhibition of the Human Ether-á-Go-Go-Related K<sup>+</sup> ChannelShifan Ma, Zhuyezi Sun, Yankang Jing, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2002
Discovery of substituted 3,4-diphenyl-thiazoles as a novel class of monoamine transporter inhibitors through 3-D pharmacophore search using a new pharmacophore model derived from mazindolIstvan J Enyedy, Jiansuo Wang, Wahiduz A Zaman, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitorsIstvan J Enyedy, Sukumar Sakamuri, Wahiduz A Zaman, et al.
Bioorganic & Medicinal Chemistry|March 5, 2003
2,3-Disubstituted quinuclidines as a novel class of dopamine transporter inhibitorsSukumar Sakamuri, Istvan J Enyedy, Wahiduz A Zaman, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|March 23, 2004
Virtual screening for kinase targetsIngo Muegge, Istvan J Enyedy
Future Medicinal Chemistry|April 1, 2015
Computational solvent mapping in structure-based drug designDavid R Hall, Istvan J Enyedy
Future Medicinal Chemistry|September 16, 2016
The use of fake ligands from computational solvent mapping in ligand and structure-based virtual screeningDavid R Hall, Istvan J Enyedy
Journal of Computer-Aided Molecular Design|January 10, 2008
Can we use docking and scoring for hit-to-lead optimization?Istvan J Enyedy, William J Egan
Bioorganic & Medicinal Chemistry Letters|January 28, 2021
The influence of calculated physicochemical properties of compounds on their ADMET profilesShifan Ma, Mark McGann, Istvan J Enyedy
Future Medicinal Chemistry|April 30, 2015
In silico prediction of hERG inhibitionYankang Jing, Alison Easter, David Peters, et al.
Chemical Research in Toxicology|July 27, 2022
Use of Solvent Mapping for Characterizing the Binding Site and for Predicting the Inhibition of the Human Ether-á-Go-Go-Related K<sup>+</sup> ChannelShifan Ma, Zhuyezi Sun, Yankang Jing, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2002
Discovery of substituted 3,4-diphenyl-thiazoles as a novel class of monoamine transporter inhibitors through 3-D pharmacophore search using a new pharmacophore model derived from mazindolIstvan J Enyedy, Jiansuo Wang, Wahiduz A Zaman, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitorsIstvan J Enyedy, Sukumar Sakamuri, Wahiduz A Zaman, et al.
Bioorganic & Medicinal Chemistry|March 5, 2003
2,3-Disubstituted quinuclidines as a novel class of dopamine transporter inhibitorsSukumar Sakamuri, Istvan J Enyedy, Wahiduz A Zaman, et al.
Pageof 2